P Formulation Development and Evaluation of Propranolol Hydrochloride Sustained Release Tablet

@inproceedings{Amulyaratna2012PFD,
  title={P Formulation Development and Evaluation of Propranolol Hydrochloride Sustained Release Tablet},
  author={Behera Amulyaratna and Patil Sachinkumar and Lade Pravinkumar and B Janaki Priyadarshini and Chandra Sekhar and Sahoo Sunit Kumar},
  year={2012}
}
Propranolol Hydrochloride, a β-adrenergic receptor antagonist is a cardiovascular agent. It is most effective in angina pectoris. It is also used in case of cardiac arrhythmia and hypertension. Sustained release formulations offer the advantages of superior patient conformity, reduced severity of undesirable effects, less fluctuations in plasma… CONTINUE READING